Search

everythinglearnresearchcommunity

for

Search:↓

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

Targeting specific miRNAs may help treat hair follicle issues caused by hydrogen peroxide.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

VEGF stimulates hair cell growth and increases growth receptor levels through a specific signaling pathway.

Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Disrupting Stat3 in hair follicle stem cells greatly reduces skin tumor formation.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Ginseng and its compounds may help hair growth and prevent hair loss, but more human trials are needed to confirm this.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Melatonin directly affects mouse hair follicles and may influence hair growth.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

DNA methylation is essential for skin and hair follicle development, and could be a target for treating skin diseases.

Minoxidil may work for hair loss by reducing androgen sensitivity and altering hormone-related enzymes.